BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29073582)

  • 1. Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients.
    Farag S; van Coevorden F; Sneekes E; Grunhagen DJ; Reyners AKL; Boonstra PA; van der Graaf WT; Gelderblom HJ; Steeghs N
    Eur J Cancer; 2017 Nov; 86():318-325. PubMed ID: 29073582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.
    Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Røsok B; Joensuu H; Bruland Ø
    Acta Oncol; 2024 May; 63():288-293. PubMed ID: 38712513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients.
    Bleckman RF; Broekman KE; Roets E; Mohammadi M; Desar IME; Gelderblom H; Mathijssen RHJ; Steeghs N; de Graeff P; Reyners AKL
    Drugs Aging; 2024 Feb; 41(2):165-176. PubMed ID: 38123766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization for gastrointestinal stromal tumors with liver metastases.
    Cao G; Li J; Shen L; Zhu X
    World J Gastroenterol; 2012 Nov; 18(42):6134-40. PubMed ID: 23155343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Access for Gastrointestinal Stromal Tumor in Predominantly Low- and Middle-Income Countries.
    Briercheck EL; Wrigglesworth JM; Garcia-Gonzalez I; Scheepers C; Ong MC; Venkatesh V; Stevenson P; Annamalay AA; Coffey DG; Anderson AB; Garcia-Gonzalez P; Wagner MJ
    JAMA Netw Open; 2024 Apr; 7(4):e244898. PubMed ID: 38568688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Imatinib on Survival and Treatment Trends for Small Bowel and Colorectal Gastrointestinal Stromal Tumors.
    Almaazmi H; Stem M; Lo BD; Taylor JP; Fang SH; Safar B; Efron JE; Atallah C
    J Gastrointest Surg; 2020 Jan; 24(1):98-108. PubMed ID: 31388887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis.
    Bischof DA; Dodson R; Jimenez MC; Behman R; Cocieru A; Blazer DG; Fisher SB; Squires MH; Kooby DA; Maithel SK; Groeschl RT; Gamblin TC; Bauer TW; Karanicolas PJ; Law C; Quereshy FA; Pawlik TM
    J Gastrointest Surg; 2015 Jun; 19(6):1022-8. PubMed ID: 25731828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Referral patterns of GIST patients: data from a nationwide study.
    Roets E; Ijzerman NS; Ho VKY; Desar IME; Reyners AKL; Gelderblom H; Grünhagen DJ; Van Etten B; Van Houdt WJ; Van der Graaf WTA; Steeghs N
    Acta Oncol; 2024 Feb; 63():28-34. PubMed ID: 38353407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study.
    Kulke MH; Benson AB; Dasari A; Huynh L; Cai B; Totev T; Roesner N; Duh MS; Neary MP; Maurer VE; Shih BE; Dagohoy CG; Chan J; Bergsland EK
    Oncologist; 2019 Aug; 24(8):1056-1065. PubMed ID: 30606883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials.
    Nagatani Y; Shitara K; Bando H; Kuboki Y; Okamoto W; Kojima T; Yoshino T; Nishida T; Ohtsu A; Doi T
    BMC Cancer; 2016 Nov; 16(1):889. PubMed ID: 27842521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local treatment in metastatic GIST patients: A multicentre analysis from the Dutch GIST Registry.
    Brink P; Kalisvaart GM; Schrage YM; Mohammadi M; Ijzerman NS; Bleckman RF; Wal T; de Geus-Oei LF; Hartgrink HH; Grunhagen DJ; Verhoef C; Sleijfer S; Oosten AW; Been LB; van Ginkel RJ; Reyners AKL; Bonenkamp HJ; Desar IME; Gelderblom H; van Houdt WJ; Steeghs N; Fiocco M; van der Hage JA
    Eur J Surg Oncol; 2023 Sep; 49(9):106942. PubMed ID: 37246093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-Based Epidemiology and Mortality of Small Malignant Gastrointestinal Stromal Tumors in the USA.
    Coe TM; Fero KE; Fanta PT; Mallory RJ; Tang CM; Murphy JD; Sicklick JK
    J Gastrointest Surg; 2016 Jun; 20(6):1132-40. PubMed ID: 27025710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination.
    Perez EA; Gutierrez JC; Jin X; Lee DJ; Rocha-Lima C; Livingstone AS; Franceschi D; Koniaris LG
    J Gastrointest Surg; 2007 Jan; 11(1):114-25. PubMed ID: 17390197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group.
    Abdalla TSA; Pieper L; Kist M; Thomaschewski M; Klinkhammer-Schalke M; Zeissig SR; Tol KK; Wellner UF; Keck T; Hummel R
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7461-7469. PubMed ID: 36959341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival.
    Garbay D; Maki RG; Blay JY; Isambert N; Piperno Neumann S; Blay C; Zanardi E; Boudou-Rouquette P; Bozec L; Duffaud F; Bertucci F; Italiano A
    Ann Oncol; 2013 Jul; 24(7):1924-1930. PubMed ID: 23493135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing gastrointestinal stromal tumor outcomes between geriatric and non-geriatric patients: A population-based analysis.
    Singh A; Chitti B; Aguiar C; Wernicke AG; Devoe CE; Rahman H; Sison C; Parashar B
    World J Surg; 2024 Jun; 48(6):1424-1432. PubMed ID: 38647223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study.
    van de Wal D; den Hollander D; Desar IME; Gelderblom H; Oosten AW; Reyners AKL; Steeghs N; Husson O; van der Graaf WTA
    Support Care Cancer; 2024 Apr; 32(5):279. PubMed ID: 38594390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of gastrointestinal stromal tumours combined with imatinib treatment: a retrospective cohort analysis.
    Bachmann R; Strohäker J; Kraume J; Königsrainer A; Ladurner R
    Transl Gastroenterol Hepatol; 2018; 3():108. PubMed ID: 30701215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Might Patients with Metastatic Gastrointestinal Stromal Tumors Benefit from Operative Management? A Population-Based Retrospective Study.
    Yue L; Sun Y; Hu M; Hu W
    Biomed Res Int; 2022; 2022():9432410. PubMed ID: 36119927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of epidemiology, survival and initial treatment in patients with gastrointestinal stromal tumour in the USA: a retrospective study based on SEER database.
    Zhu H; Yang G; Ma Y; Huo Q; Wan D; Yang Q
    BMJ Open; 2023 Jul; 13(7):e072945. PubMed ID: 37419634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.